SCHEMBL17698455

SCHEMBL17698455

COc1[c]ccc(C)c1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2352053 0.80
SCHEMBL15390290 0.78 CA12 (0.33)
SCHEMBL457306 0.77
SCHEMBL2344169 0.77 HTR2A (0.31)
SCHEMBL15352615 0.77
SCHEMBL8196392 0.76 KDM4E (0.32)
SCHEMBL11278659 0.74
SCHEMBL5329541 0.74 TUBB1 (0.30)
SCHEMBL8879586 0.73
SCHEMBL3909730 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021078120-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES NOVARTIS AG (CH) 2021-04-29 WO claimed
EP-2262500-B1 THIENOPYRIDONE DERIVATIVES AS AMP-ACTIVATED PROTEIN KINASE (AMPK) ACTIVATORS MERCK PATENT GMBH (DE) 2016-04-27 EP disclosed